Nanochon
Washington, US · Founded 2021 · Delaware corporation · 3 known investors
Nanochon develops Chondrograft, a fully synthetic, 3D-printed surgical implant for cartilage repair aimed at adults with significant cartilage damage who are too young for total knee replacement. The off-the-shelf orthopedic device is designed for surgeons to restore joint function and support tissue repair, with an initial clinical trial launching in Canada.
BiotechHardwareHealthtechMedical Devices
Founders & leadership
BH
Benjamin HolmesExecutive Officer, Director
NP
Nick PachudaDirector
KJ
Kurt JacobusDirector
RC
Robert CreedenDirector
SC
Sean ChurchillDirector
NC
Nathan CastroExecutive Officer, Director
BH
Ben HolmesCEO & Co-founder
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$3.6MraisedFeb 2026 · 39 investors · BiotechnologyRule 506(b)
▶$3.6MraisedFeb 2026 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin HolmesExecutive Officer, Director
- Nick PachudaDirector
- Kurt JacobusDirector
- Robert CreedenDirector
- Sean ChurchillDirector
- Offering amount
- $4.2M
- Amount sold
- $3.6M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$4MraisedMay 2024 · 34 investors · Other TechnologyRule 506(b)
▶$4MraisedMay 2024 · 34 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin HolmesExecutive Officer, Director
- Greg HornerDirector
- Robert CreedenDirector
- Nick PachudaDirector
- Kurt JacobusDirector
- Offering amount
- $6M
- Amount sold
- $4M
- Minimum investment
- $999
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedOct 2021 · 17 investors · Other TechnologyRule 506(b)
▶$2MraisedOct 2021 · 17 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin HolmesExecutive Officer, Director
- Nathan CastroExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- Minimum investment
- $10K
- Proceeds to insiders
- $100K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.